Aurora Cannabis Inc. announced the availability of medical cannabis concentrates, specifically proprietary cultivar-specific inhalable cannabis extracts, to patients in the United Kingdom. This launch marks a meaningful step in expanding the company's patient offering in the UK market.
The new products include two novel Aurora 1.2g resin cartridges derived from highly sought-after proprietary cultivars: Sourdough (indica) and Electric Honeydew (sativa). These inhalable cartridges offer a convenient and discreet consumption option, providing fast and controlled delivery of medical cannabis.
These products are already available to patients in Canada and Australia, and their introduction to the UK reinforces Aurora's commitment to expanding patient access to a greater variety of high-quality, premium medical cannabis globally.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.